Roberto Bianchi

BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then.

Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy.

Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy.

BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then.

BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then.